MeSH tree: D04.210.500.221.430.342.925
The search for long COVID treatments continues, as a randomized clinical trial found that a two-week course of metformin or ursodeoxycholic acid (UDCA) did not meaningfully improve recovery from symptoms, despite earlier ...
Mar 3, 2026
0
14
Osteoarthritis (OA) is one of the most prevalent conditions affecting tens of millions of U.S. adults, traditionally understood as a disease driven primarily by mechanical wear and tear. This perspective is being reshaped ...
Apr 16, 2025
0
49
Researchers across 14 medical centers in China, including Peking University People's Hospital, have found that an investigational drug, berberine ursodeoxycholate (HTD1801), significantly lowered blood sugar levels and improved ...
Immunotherapy is a modern approach to cancer treatment that uses a patient's own immune system to help fight tumors. It has made an incredible impact on treating cancers in many different organ systems, including the lung, ...
Jan 14, 2025
0
63
Cholestatic liver diseases (CLDs) are a group of disorders characterized by the impairment of bile formation, secretion, or excretion. This impairment leads to bile acid accumulation in the liver, causing liver biochemical ...
Jul 12, 2024
0
50
For patients with primary biliary cholangitis, more receiving the peroxisome proliferator-activated receptor delta (PPARδ) agonist seladelpar have a biochemical response and alkaline phosphatase normalization, according to ...
Feb 27, 2024
0
27
SARS-CoV-2, the virus that causes COVID-19, attaches to a cellular receptor called angiotensin-converting enzyme 2 (ACE2), and activation of the farnesoid X receptor increases ACE2 expression. New research published in the ...
Apr 5, 2023
0
39
Cambridge scientists have identified an off-patent drug that can be repurposed to prevent COVID-19—and may be capable of protecting against future variants of the virus—in research involving a unique mix of "mini-organs," ...
Dec 5, 2022
0
237
A closely watched experimental drug for Lou Gehrig's disease got an unusual second look from U.S. regulators on Wednesday, following intense pressure to approve the treatment for those with the fatal illness.
Sep 7, 2022
0
37
